Investing in Cancer Research


In Australia it is estimated there will be just under


New cancer cases will be diagnosed and just under 50,000 deaths from cancer in 2020.[1]

Can Too has invested in

32 cancer treatment research projects

to improve outcomes for cancer patients. 

In 2020 Can Too is funding research by Dr Arutha Kulasinghe and Dr Simone Park

Can Too Cancer Research Cancer Treatment

Nearly seven out of ten Australians diagnosed with cancer today will survive more than five years past their diagnosis thanks to cancer research discoveries. [2]

What Are Cancer Treatments?

Most cancers are treated with surgery, chemotherapy and/or radiotherapy. Treatments such as hormone therapy, immunotherapy and targets therapies are also available for some types of cancers.

Dr Bree Foley of the Telethon Kids Institute at the University of WA (UWA) has been interested in immunology – the study of the body’s immune system – since she started her undergraduate career at UWA in 2000. “I find it fascinating how intricate the immune system is and how it works constantly to keep us from harm,” she says.

Bree is excited that harnessing of the body’s own resources to fight cancer is, increasingly, becoming a clinical reality. Her Cure Cancer Australia and Can Too funded research is focused on understanding how scientists can support the human body to do it. In particular, she’s interested in a “subset” of cells known as natural killers (NK) which help the immune system to reject tumours.

The Can Too Foundation has invested in 24 researchers who are improving outcomes for cancer patients since 2005.

Australian Institute of Health and Welfare. Cancer data in Australia. (2020) Retrieved from URL: Cancer Council. Looking Ahead a Cancer Free Future. Retrieved from URL: